4//SEC Filing
DRACHMAN JONATHAN G 4
Accession 0001209191-21-038690
CIK 0001404644other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:06 PM ET
Size
7.1 KB
Accession
0001209191-21-038690
Insider Transaction Report
Form 4
DRACHMAN JONATHAN G
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2021-06-03$9.48/sh+40,000$379,272→ 2,238,686 total - Purchase
Common Stock
2021-06-04$9.61/sh+10,000$96,082→ 2,248,686 total
Footnotes (2)
- [F1]Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.38 and the highest price at which shares were purchased was $9.51. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.56 and the highest price at which shares were purchased was $9.62.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001588467
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 5:06 PM ET
- Size
- 7.1 KB